Syncom Formulations (India) (SYNCOMF.NS) Stock Price
Syncom Formulations (India) Price
Over the last 19 years Syncom Formulations (India) grew revenue by 11.9% annually, reaching 4.89 B INR. Earnings per share have grown at 16.7% per year over the last 19 years. For Syncom Formulations (India), the net margin of 15.6% is up versus 9.1% a few years ago. At today's price the dividend yield works out to roughly 0.12%. The payout ratio is around 14% of earnings. The dividend has grown at 15.8% per year over the past 16 years.
Syncom Formulations (India) stock price
Syncom Formulations (India) business model & stock analysis
Frequently asked questions about Syncom Formulations (India)
Converted at the current exchange rate, the Syncom Formulations (India) share trades at 0.23 EUR (24.94 INR).
The revenue of Syncom Formulations (India) is 4.89 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Syncom Formulations (India) is 764.38 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Syncom Formulations (India) is currently 30.67. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Syncom Formulations (India) stock.
The price-to-sales ratio (P/S) of Syncom Formulations (India) is currently 4.79. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Syncom Formulations (India) stock.
The Eulerpool Quality Score for Syncom Formulations (India) is 7/10.
The ISIN of Syncom Formulations (India) is INE312C01025. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Syncom Formulations (India) is SYNCOMF.NS. The ticker symbol is used to trade Syncom Formulations (India) shares on the stock exchange.
Syncom Formulations (India) stock
Syncom Formulations (India) Peer Group
Syncom Formulations (India) FIGI
All fundamentals and in-depth analysis of Syncom Formulations (India)
Our stock analysis for Syncom Formulations (India) stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Syncom Formulations (India). If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.